Envista Holdings Corporation

US$25.17As of Sun 8 Nov 2026, 12:00 UTC
NYSE:NVSTHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (1.43%)
Div yield —
ROE 20.52%
Medical Instruments & Supplies
Beta (5Y) 0.94
PE TTM 6.541
TSR TTM 23.69%
Mkt cap US$4.036B
ROIC 8.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$32
27.91%
30.59%
Buy 12|10|12|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.30
0.32
0.33
0.35
8.88%
14.82%
19.28%
17.55%
Revenue$M
408.7
403.5
425.1
445.0
0.34%
(3.72%)
(0.37%)
6.61%
Peers (US$4.036B)
Cap (US$)
PE
4.304B
71.81x
4.082B
27.61x
Capital
TTM
5Y
10Y
Leveragex
0.184
3.216
2.492
EBIT/Intx
0.602
1.054
0.951
Own earn%
116.30
(46.66)
(49.30)
Sh yield%
30.52
34.25
39.60
Owners
Insiders/Inst%
0.28
72.51
Short interest%
4.11
SBC / revenue%
3.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
2–10
$1 testx
0.1
Incr. ROIC%
5